x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d)
|
|||
OF
THE SECURITIES EXCHANGE ACT OF 1934
|
||||
For
the quarterly period ended: April 7, 2007
|
||||
OR
|
||||
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d)
|
|||
OF
THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
75-2018505
|
|
(State
or other jurisdiction of incorporation
or
organization)
|
(I.R.S.
Employer Identification No.)
|
Large
accelerated filer x
|
Accelerated
filer o
|
Non-accelerated
filer o
|
Item
1.
|
Financial
Statements
|
April
7,
2007
|
January
6,
2007
|
|||||||
ASSETS
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ |
141,548
|
$ |
133,304
|
||||
Securities
available for sale
|
7,199
|
6,894
|
||||||
Accounts
receivable – net of allowances of $34.3 million and $38.3 million for 2007
and 2006, respectively
|
151,886
|
155,236
|
||||||
Inventories
- net
|
235,627
|
228,225
|
||||||
Deferred
income tax assets
|
20,374
|
20,406
|
||||||
Prepaid
expenses and other current assets
|
45,439
|
36,923
|
||||||
Total
current assets
|
602,073
|
580,988
|
||||||
Investments
|
11,866
|
10,855
|
||||||
Property,
plant and equipment – net of accumulated depreciation of $114,044 and
$109,183 for 2007 and 2006, respectively
|
169,900
|
171,499
|
||||||
Goodwill
|
44,638
|
43,038
|
||||||
Intangible
and other assets – net of accumulated amortization of
$4,335 and $3,990 for 2007 and 2006,
respectively
|
46,468
|
46,217
|
||||||
Total
assets
|
$ |
874,945
|
$ |
852,597
|
||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
||||||||
Current
liabilities:
|
||||||||
Short-term
debt
|
$ |
11,474
|
$ |
11,338
|
||||
Accounts
payable
|
46,401
|
53,306
|
||||||
Accrued
expenses:
|
||||||||
Accrued
accounts payable
|
22,525
|
23,562
|
||||||
Compensation
|
28,687
|
28,896
|
||||||
Coop
advertising
|
8,615
|
11,554
|
||||||
Other
|
34,734
|
41,653
|
||||||
Income
taxes payable
|
36,906
|
53,071
|
||||||
Total
current liabilities
|
189,342
|
223,380
|
||||||
Long-term
income taxes payable
|
29,475
|
-
|
||||||
Deferred
income tax liabilities
|
15,623
|
15,021
|
||||||
Other
long-term liabilities
|
7,761
|
7,893
|
||||||
Total
long-term liabilities
|
52,859
|
22,914
|
||||||
Minority
interest in subsidiaries
|
3,243
|
4,102
|
||||||
Stockholders’
equity:
|
||||||||
Common
stock, 68,107 and 67,794 shares
issued, respectively
|
681
|
678
|
||||||
Additional
paid-in capital
|
56,939
|
53,459
|
||||||
Retained
earnings
|
550,258
|
529,376
|
||||||
Accumulated
other comprehensive income
|
23,617
|
20,025
|
||||||
Treasury
stock at cost, 95 and 69 shares, respectively
|
(1,994 | ) | (1,337 | ) | ||||
Total
stockholders’ equity
|
629,501
|
602,201
|
||||||
Total
liabilities and stockholders’ equity
|
$ |
874,945
|
$ |
852,597
|
For
the 13
Weeks
Ended
April
7, 2007
|
For
the 14
Weeks
Ended
April
8, 2006
|
|||||||
Net
sales
|
$ |
304,825
|
$ |
264,225
|
||||
Cost
of sales
|
148,706
|
131,211
|
||||||
Gross
profit
|
156,119
|
133,014
|
||||||
Operating
expenses:
|
||||||||
Selling
and distribution
|
86,367
|
84,980
|
||||||
General
and administrative
|
37,197
|
31,042
|
||||||
Total
operating expenses
|
123,564
|
116,022
|
||||||
Operating
income
|
32,555
|
16,992
|
||||||
Interest
expense
|
221
|
596
|
||||||
Other
income (expense) – net
|
1,495
|
(904 | ) | |||||
Income
before income taxes
|
33,829
|
15,492
|
||||||
Provision
for income taxes
|
8,797
|
5,776
|
||||||
Net
income
|
$ |
25,032
|
$ |
9,716
|
||||
Other
comprehensive income, net of taxes:
|
||||||||
Currency
translation adjustment
|
4,523
|
2,136
|
||||||
Unrealized
gain on securities available for sale
|
384
|
10
|
||||||
Forward
contracts hedging intercompany foreign currency payments – change in fair
values
|
(1,314 | ) | (783 | ) | ||||
Total
comprehensive income
|
$ |
28,625
|
$ |
11,079
|
||||
Earnings
per share:
|
||||||||
Basic
|
$ |
0.37
|
$ |
0.14
|
||||
Diluted
|
$ |
0.36
|
$ |
0.14
|
||||
Weighted
average common shares outstanding:
|
||||||||
Basic
|
67,576
|
67,258
|
||||||
Diluted
|
69,238
|
69,060
|
For
the 13
Weeks
Ended
April
7, 2007
|
For
the 14
Weeks
Ended
April
8, 2006
|
|||||||
Operating
activities:
|
||||||||
Net
income
|
$ |
25,032
|
$ |
9,716
|
||||
Noncash
items affecting net income:
|
||||||||
Minority
interest in subsidiaries
|
1,192
|
851
|
||||||
Equity
in earnings of joint venture
|
(327 | ) | (269 | ) | ||||
Depreciation
and amortization
|
8,031
|
7,805
|
||||||
Stock
- based compensation
|
458
|
387
|
||||||
Excess tax
benefits from stock-based compensation
|
(1,021 | ) | (408 | ) | ||||
Loss
(gain) on disposal of assets
|
76
|
(23 | ) | |||||
Decrease
in allowance for doubtful accounts
|
(138 | ) | (271 | ) | ||||
Decrease
in allowance for returns - net of related inventory in
transit
|
(1,111 | ) | (320 | ) | ||||
Deferred
income taxes
|
(598
|
) | (2,154 | ) | ||||
Changes
in operating assets and liabilities, net of effects of
acquisitions:
|
||||||||
Accounts
receivable
|
7,400
|
20,578
|
||||||
Inventories
|
(10,203 | ) | (11,529 | ) | ||||
Prepaid
expenses and other current assets
|
(8,516 | ) | (5,002 | ) | ||||
Accounts
payable
|
(11,111 | ) | (13,425 | ) | ||||
Accrued
expenses
|
(11,725 | ) | (4,938 | ) | ||||
Income
taxes payable
|
9,524
|
5,908
|
||||||
Net
cash from operating activities
|
6,963
|
6,906
|
||||||
Investing
activities:
|
||||||||
Business
acquisitions, net of cash acquired
|
-
|
(6,075 | ) | |||||
Additions
to property, plant and equipment
|
(4,006 | ) | (14,764 | ) | ||||
Purchase
of securities available for sale
|
(325 | ) | (321 | ) | ||||
Increase
in intangible and other assets
|
(448 | ) | (558 | ) | ||||
Net
cash used in investing activities
|
(4,779 | ) | (21,718 | ) | ||||
Financing
activities:
|
||||||||
Proceeds
from exercise of stock options
|
4,139
|
1,247
|
||||||
Acquisition
and retirement of common stock
|
(287 | ) | (22,370 | ) | ||||
Excess
tax benefits from stock - based compensation
|
1,021
|
408
|
||||||
Distribution
of minority interest earnings
|
(2,049 | ) | (186 | ) | ||||
Net
(payments) borrowings on short-term debt
|
(62 | ) |
38,165
|
|||||
Net
cash from financing activities
|
2,762
|
17,264
|
||||||
Effect
of exchange rate changes on cash and cash equivalents
|
3,298
|
1,270
|
||||||
Net
increase in cash and cash equivalents
|
8,244
|
3,722
|
||||||
Cash
and cash equivalents:
|
||||||||
Beginning
of period
|
133,304
|
57,457
|
||||||
End
of period
|
$ |
141,548
|
$ |
61,179
|
1.
|
FINANCIAL
STATEMENT POLICIES
|
For
the 13
Weeks
Ended
April
7, 2007
|
For
the 14
Weeks
Ended
April
8, 2006
|
|||||||
Numerator:
|
||||||||
Net
income
|
$ |
25,032
|
$ |
9,716
|
||||
Denominator:
|
||||||||
Basic
EPS computation:
|
||||||||
Weighted
average common shares outstanding
|
67,576
|
67,258
|
||||||
Basic
EPS
|
$ |
0.37
|
$ |
0.14
|
||||
Diluted
EPS computation:
|
||||||||
Denominator:
|
||||||||
Basic
weighted average common shares outstanding
|
67,576
|
67,258
|
||||||
Dilutive
effect of stock-based compensation
|
1,662
|
1,802
|
||||||
Weighted
average common shares outstanding
|
69,238
|
69,060
|
||||||
Diluted
EPS
|
$ |
0.36
|
$ |
0.14
|
IN
THOUSANDS
|
United
States
|
Europe
|
Other
International
|
Direct
to
Consumer
|
Total
|
|||||||||||||||
Balance
at January 6, 2007
|
$ |
21,799
|
$ |
17,518
|
3,721
|
$ |
-
|
$ |
43,038
|
|||||||||||
Acquisitions
|
-
|
- |
1,326
|
-
|
1,326
|
|||||||||||||||
Currency
|
-
|
297
|
(23 | ) |
-
|
274
|
||||||||||||||
Balance
at April 7, 2007
|
$ |
21,799
|
$ |
17,815
|
5,024
|
$ |
-
|
$ |
44,638
|
2.
|
INVENTORIES
|
Fiscal
Year
|
April
7,
2007
|
January
7,
2006
|
||||||
IN
THOUSANDS
|
||||||||
Components
and parts
|
$ |
7,681
|
$ |
9,786
|
||||
Work-in-process
|
1,659
|
1,691
|
||||||
Finished
merchandise on hand
|
186,488
|
175,519
|
||||||
Merchandise
at Company stores
|
33,315
|
31,807
|
||||||
Merchandise
from estimated customer returns
|
18,695
|
21,496
|
||||||
247,838
|
240,299
|
|||||||
Inventory
reserve for obsolescence
|
(12,211 | ) | (12,074 | ) | ||||
Inventories
- net
|
$ |
235,627
|
$ |
228,225
|
3.
|
INCOME
TAXES
|
4.
|
STOCK-BASED
COMPENSATION PLANS
|
Options
and Stock Appreciation Rights
|
Shares
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Remaining
Contractual
Term
(years)
|
Aggregate
Intrinsic
Value
|
||||||||||||
|
IN
THOUSANDS
|
IN
THOUSANDS
|
||||||||||||||
Outstanding
at January 6, 2007
|
4,924
|
$ |
14.28
|
5.0
|
$ |
70,324
|
||||||||||
Granted
|
110
|
$ |
23.99
|
|||||||||||||
Exercised
|
(319 | ) | $ |
12.99
|
$ |
4,177
|
||||||||||
Forfeited
or expired
|
(50 | ) | $ |
20.48
|
||||||||||||
Outstanding
at April 7, 2007
|
4,665
|
$ |
14.53
|
5.2
|
$ |
67,794
|
||||||||||
Exercisable
at April 7, 2007
|
4,052
|
$ |
13.92
|
4.9
|
$ |
56,416
|
||||||||||
Nonvested
at April 7, 2007
|
613
|
$ |
18.55
|
7.4
|
$ |
11,378
|
||||||||||
Expected to vest | 552 | $ | 18.55 | 7.4 | $ | 10,240 |
Options
and Stock Appreciation Rights
Outstanding
|
Options
and Stock Appreciation Rights Exercisable
|
||||||||||||||||||||
Range
of
Exercise
Prices
|
Number
of
Shares
|
Weighted-
Average
Exercise
Price
|
Weighted-
Average
Remaining
Contractual
Life
(Yrs.)
|
Number
of
Shares
|
Weighted-
Average
Exercise
Price
|
||||||||||||||||
$0.00
– $3.14
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||
3.14
– 6.28
|
442.1
|
4.71
|
1.7
|
442.1
|
4.71
|
||||||||||||||||
6.28
– 9.42
|
1,414.4
|
8.31
|
3.4
|
1,414.4
|
8.31
|
||||||||||||||||
9.42
– 12.56
|
672.8
|
11.57
|
5.3
|
558.2
|
11.56
|
||||||||||||||||
12.56
– 15.70
|
99.5
|
13.33
|
5.4
|
81.4
|
13.29
|
||||||||||||||||
15.70
– 18.83
|
344.4
|
18.38
|
7.6
|
108.9
|
18.39
|
||||||||||||||||
18.83
– 21.97
|
774.3
|
19.25
|
6.6
|
686.7
|
19.19
|
||||||||||||||||
21.97
– 25.11
|
147.1
|
23.01
|
7.9
|
35.3
|
23.53
|
||||||||||||||||
25.11
– 28.25
|
682.9
|
25.83
|
7.4
|
637.1
|
25.83
|
||||||||||||||||
28.25
– 31.39
|
87.7
|
29.50
|
7.4
|
87.8
|
29.50
|
||||||||||||||||
Total
|
4,665.2
|
14.53
|
5.2
|
4,051.9
|
13.92
|
Weighted
Average
|
||||||||
Restricted
Stock and Restricted Stock Units
|
Shares
|
Grant-Date
Fair Value
|
||||||
IN
THOUSANDS
|
||||||||
Nonvested
at January 6, 2007
|
435
|
$ |
18.62
|
|||||
Granted
|
102
|
$ |
25.27
|
|||||
Vested
|
(67 | ) | $ |
17.62
|
||||
Forfeited
|
(7 | ) | $ |
18.41
|
||||
Nonvested
at April 7, 2007
|
463
|
$ |
20.24
|
|||||
Expected to vest | 417 | $ | 20.24 |
5.
|
SEGMENT
INFORMATION
|
For
the 13 Weeks Ended
April
7, 2007
|
For
the 14 Weeks Ended
April
8, 2006
|
|||||||||||||||
Net
Sales
|
Operating
Income
(Loss)
|
Net
Sales
|
Operating
Income
(Loss)
|
|||||||||||||
IN
THOUSANDS
|
||||||||||||||||
U.S.
wholesale:
|
||||||||||||||||
External
customers
|
$ |
106,635
|
$ | (3,370 | ) | $ |
106,519
|
$ | (9,140 | ) | ||||||
Intersegment
|
32,566
|
-
|
28,287
|
-
|
||||||||||||
Direct
to consumer
|
47,238
|
426
|
38,982
|
(449 | ) | |||||||||||
Europe
– wholesale:
|
||||||||||||||||
External
customers
|
100,624
|
17,695
|
81,275
|
6,941
|
||||||||||||
Intersegment
|
57,299
|
-
|
47,944
|
-
|
||||||||||||
Other
international – wholesale:
|
||||||||||||||||
External
customers
|
50,328
|
17,804
|
37,449
|
19,640
|
||||||||||||
Intersegment
|
87,811
|
-
|
80,542
|
-
|
||||||||||||
Intersegment
items
|
(177,676 | ) |
-
|
(156,773 | ) |
-
|
||||||||||
Consolidated
|
$ |
304,825
|
$ |
32,555
|
$ |
264,225
|
$ |
16,992
|
Percentage
of
Net
Sales
|
Percentage
Change
|
|||||||||||
For
the 13
Weeks
Ended
April
7, 2007
|
For
the 14
Weeks
Ended
April
8, 2006
|
For
the 13
Weeks
Ended
April
7, 2007
|
||||||||||
Net
sales
|
100.0 | % | 100.0 | % | 15.4 | % | ||||||
Cost
of sales
|
48.8
|
49.7
|
13.3
|
|||||||||
Gross
profit
|
51.2
|
50.3
|
17.4
|
|||||||||
Selling
and distribution expenses
|
28.3
|
32.2
|
1.6
|
|||||||||
General
and administrative expenses
|
12.2
|
11.7
|
19.8
|
|||||||||
Operating
income
|
10.7
|
6.4
|
91.6
|
|||||||||
Interest
expense
|
(0.1 | ) | (0.2 | ) | (62.9 | ) | ||||||
Other
income (expense) - net
|
0.5
|
(0.3 | ) | (265.4 | ) | |||||||
Income
before income taxes
|
11.1
|
5.9
|
118.4
|
|||||||||
Income
taxes
|
2.9
|
2.2
|
52.3
|
|||||||||
Net
income
|
8.2 | % | 3.7 | % | 157.6 | % |
Amounts
|
%
of Total
|
|||||||||||||||
For
the 13 Weeks Ended April 7, 2007
|
For
the 14 Weeks Ended April 8, 2006
|
For
the 13 Weeks Ended April 7, 2007
|
For
the 14 Weeks Ended April 8, 2006
|
|||||||||||||
International
wholesale:
|
||||||||||||||||
Europe
|
$ |
100.6
|
$ |
81.3
|
33.0 | % | 30.8 | % | ||||||||
Other
|
50.3
|
37.4
|
16.5
|
14.1
|
||||||||||||
Total
international wholesale
|
150.9
|
118.7
|
49.5
|
44.9
|
||||||||||||
Domestic
wholesale:
|
||||||||||||||||
Watch
products
|
46.5
|
48.6
|
15.3
|
18.4
|
||||||||||||
Other
products
|
60.2
|
57.9
|
19.7
|
21.9
|
||||||||||||
Total
domestic wholesale
|
106.7
|
106.5
|
35.0
|
40.3
|
||||||||||||
Direct
to consumer
|
47.2
|
39.0
|
15.5
|
14.8
|
||||||||||||
Total
net sales
|
$ |
304.8
|
$ |
264.2
|
100.0 | % | 100.0 | % |
Analysis
of Percentage Change in Sales Versus Prior Year Quarter
|
||||||||||||||||
Attributable
to Changes in the Following Factors
|
||||||||||||||||
Exchange
Rates
|
Acquisitions
|
Organic
Growth
|
Total
Change
|
|||||||||||||
Europe
wholesale
|
9.1 | % | 0.0 | % | 14.7 | % | 23.8 | % | ||||||||
Other
international wholesale
|
0.2 | % | 1.4 | % | 32.8 | % | 34.4 | % | ||||||||
Domestic
wholesale
|
0.0 | % | 0.0 | % | 0.1 | % | 0.1 | % | ||||||||
Direct
to consumer
|
0.9 | % | 0.0 | % | 20.3 | % | 21.2 | % | ||||||||
Total
|
3.0 | % | 0.2 | % | 12.2 | % | 15.4 | % |
Amounts
|
%
of Net Sales
|
|||||||||||||||
Segment
|
For
the 13
Weeks
Ended
April
7, 2007
|
For
the 14
Weeks
Ended
April
8, 2006
|
For
the 13
Weeks
Ended
April
7, 2007
|
For
the 14
Weeks
Ended
April
8, 2006
|
||||||||||||
Europe
wholesale
|
$ |
34.5
|
$ |
30.9
|
34.2 | % | 38.0 | % | ||||||||
Other
international wholesale
|
14.6
|
12.5
|
29.0
|
33.5
|
||||||||||||
Domestic
wholesale (1)
|
49.1
|
50.7
|
46.0
|
47.6
|
||||||||||||
Direct
to consumer
|
25.4
|
21.9
|
53.8
|
56.2
|
||||||||||||
Total
|
$ |
123.6
|
$ |
116.0
|
40.5
|
% |
43.9
|
% |
|
·
|
We
will institute internal audit procedures relating to the equity-based
compensation awards approval and documentation process; engage
an
independent compensation consultant and/or independent counsel
(at least
for a transitional period) and focus on improving the Compensation
Committee approval and oversight process; designate specific members
of
in-house legal, accounting, and human resources staffs to oversee
documentation, accounting and disclosure of all equity-based compensation
awards; widely distribute and explain enhanced equity grant processes
and
documentation requirements; increase automation of the equity grant
record
keeping process; improve process and controls regarding delegated
grant
authority; and improve training and education designed to ensure
that all
relevant personnel involved in the administration of equity-based
compensation awards understand relevant policies and
requirements.
|
|
·
|
Annual
grants will be determined in connection with annual performance
reviews of
employees, including executives. Generally, one annual grant date
will apply to all annual grants to U.S. employees, and another
annual
grant date will apply to all annual grants to employees outside
of the
United States.
|
|
(a)
|
Exhibits
|
31.1
|
Certification
of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities
Exchange Act of 1934.
|
31.2
|
Certification
of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities
Exchange Act of 1934.
|
32.1
|
Certification
of Chief Executive Officer pursuant to Rule 13a-14(b) of the Securities
Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant
to
Section 906 of the Sarbanes-Oxley Act of 2002.
|
32.2
|
Certification
of Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities
Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant
to
Section 906 of the Sarbanes-Oxley Act of
2002.
|
FOSSIL,
INC.
|
||||
Date:
August 8, 2007
|
By:
|
/s/
Mike L. Kovar
|
||
Mike
L. Kovar
|
||||
Senior
Vice President, Chief Financial Officer and Treasurer
|
||||
(Principal
financial and accounting officer duly authorized to sign on behalf
of
Registrant)
|
Exhibit
Number
|
Document
Description
|
|
Certification
of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities
Exchange Act of 1934.
|
||
Certification
of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities
Exchange Act of 1934.
|
||
Certification
of Chief Executive Officer pursuant to Section 18 U.S.C. Section
1350, as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
||
Certification
of Chief Financial Officer pursuant to Section 18 U.S.C. Section
1350, as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|